QQQ   419.50 (-0.92%)
AAPL   165.24 (-1.08%)
MSFT   402.14 (-0.53%)
META   488.94 (-2.56%)
GOOGL   154.88 (-0.72%)
AMZN   176.24 (-1.66%)
TSLA   149.67 (-0.17%)
NVDA   823.50 (-2.74%)
AMD   150.42 (-3.00%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.28 (-0.31%)
F   12.12 (+0.50%)
MU   108.10 (-3.42%)
GE   150.83 (-1.38%)
CGC   7.78 (-0.64%)
DIS   111.89 (-0.48%)
AMC   3.10 (+6.16%)
PFE   25.73 (+1.34%)
PYPL   62.09 (-0.02%)
XOM   120.18 (+1.40%)
QQQ   419.50 (-0.92%)
AAPL   165.24 (-1.08%)
MSFT   402.14 (-0.53%)
META   488.94 (-2.56%)
GOOGL   154.88 (-0.72%)
AMZN   176.24 (-1.66%)
TSLA   149.67 (-0.17%)
NVDA   823.50 (-2.74%)
AMD   150.42 (-3.00%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.28 (-0.31%)
F   12.12 (+0.50%)
MU   108.10 (-3.42%)
GE   150.83 (-1.38%)
CGC   7.78 (-0.64%)
DIS   111.89 (-0.48%)
AMC   3.10 (+6.16%)
PFE   25.73 (+1.34%)
PYPL   62.09 (-0.02%)
XOM   120.18 (+1.40%)
QQQ   419.50 (-0.92%)
AAPL   165.24 (-1.08%)
MSFT   402.14 (-0.53%)
META   488.94 (-2.56%)
GOOGL   154.88 (-0.72%)
AMZN   176.24 (-1.66%)
TSLA   149.67 (-0.17%)
NVDA   823.50 (-2.74%)
AMD   150.42 (-3.00%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.28 (-0.31%)
F   12.12 (+0.50%)
MU   108.10 (-3.42%)
GE   150.83 (-1.38%)
CGC   7.78 (-0.64%)
DIS   111.89 (-0.48%)
AMC   3.10 (+6.16%)
PFE   25.73 (+1.34%)
PYPL   62.09 (-0.02%)
XOM   120.18 (+1.40%)
QQQ   419.50 (-0.92%)
AAPL   165.24 (-1.08%)
MSFT   402.14 (-0.53%)
META   488.94 (-2.56%)
GOOGL   154.88 (-0.72%)
AMZN   176.24 (-1.66%)
TSLA   149.67 (-0.17%)
NVDA   823.50 (-2.74%)
AMD   150.42 (-3.00%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.28 (-0.31%)
F   12.12 (+0.50%)
MU   108.10 (-3.42%)
GE   150.83 (-1.38%)
CGC   7.78 (-0.64%)
DIS   111.89 (-0.48%)
AMC   3.10 (+6.16%)
PFE   25.73 (+1.34%)
PYPL   62.09 (-0.02%)
XOM   120.18 (+1.40%)
Free Trial

PhaseBio Pharmaceuticals (PHAS) Insider Trading & Ownership

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)
Free PHAS Stock Alerts
Compare
Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaSustainability

PhaseBio Pharmaceuticals (NASDAQ:PHAS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
9.90%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$30,000.00
Number Of
Insiders Selling
(Last 3 Years)
2
Amount Of
Insider Selling
(Last 3 Years)
$302,705.88
Get PHAS Insider Trade Alerts

Want to know when executives and insiders are buying or selling PhaseBio Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

PHAS Insider Buying and Selling by Quarter

Ad InvestorPlace
New crypto project uncovers 2,050% in 65 days
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
Just click here to sign up and be among the first to get it.

PhaseBio Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/25/2022Enterprise Associates 13 L NewMajor ShareholderSell1,784,109$0.15$267,616.35  
5/23/2022Glen BurkhardtSVPSell11,248$0.79$8,885.92  
11/19/2021Glen BurkhardtVPSell5,766$2.37$13,665.42  
8/18/2021Clay ThorpDirectorBuy10,000$3.00$30,000.00  
5/20/2021Glen BurkhardtVPSell3,811$3.29$12,538.19  
(Data available from 1/1/2013 forward)

PHAS Insider Trading Activity - Frequently Asked Questions

Who is on PhaseBio Pharmaceuticals's Insider Roster?

The list of insiders at PhaseBio Pharmaceuticals includes Clay Thorp, Enterprise Associates 13 L New, and Glen Burkhardt. Learn more on insiders at PHAS.

What percentage of PhaseBio Pharmaceuticals stock is owned by insiders?

9.90% of PhaseBio Pharmaceuticals stock is owned by insiders. Learn more on PHAS's insider holdings.

Which PhaseBio Pharmaceuticals insiders have been selling company stock?

The following insiders have sold PHAS shares in the last 24 months: Enterprise Associates 13 L New ($267,616.35), and Glen Burkhardt ($8,885.92).

How much insider selling is happening at PhaseBio Pharmaceuticals?

Insiders have sold a total of 1,795,357 PhaseBio Pharmaceuticals shares in the last 24 months for a total of $276,502.27 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:PHAS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
My biggest AI fear
Paradigm Press
How Biden has already won 2024
Porter & Company
Options trading has suddenly become more reliable.
Eagle Publishing